Cromos Pharma, where the patients are

Awards & Advancement

Icon appoints Dariush Elahi head of metabolic research, early phase

Monday, January 20, 2014 01:20 AM

Global CRO Icon has appointed Dr. Dariush Elahi director of metabolic research. Based in Icon’s Clinical Pharmacology Unit in San Antonio, U.S., Elahi will lead Icon’s early phase glucose clamping programs globally, providing expert, scientific consultation to sponsors who are developing therapeutic agents to treat endocrine/metabolic disease.

More... »

CRF Health eCOA webinar series

Novasep hires Thierry Van Nieuwenhove as president of Synthesis Business Unit

Monday, January 20, 2014 01:00 AM

Novasep, a supplier of manufacturing solutions to the life sciences industry, has appointed Thierry van Nieuwenhove president of the Synthesis Business Unit. Van Nieuwenhove’s arrival completes Novasep’s executive committee.

More... »


INC Research reinforces Japan presence with key leadership appointments

Wednesday, January 15, 2014 03:58 PM

INC Research, a therapeutically focused global CRO with a Trusted Process for delivering reliable results, has announced three key management appointments to enhance its growing presence and clinical R&D leadership team in Japan. Hiromi Wakita, Ph.D., has joined the company as general manager and clinical director and will lead the company’s operations in Japan. He is supported by the appointments of Hiroshi Uoji, who joins as regulatory and safety director for Japan, and Shinichi Sato, who joins as project director, CNS Clinical Development in Japan. With these appointments, INC Research is able to offer its global drug development customers a highly qualified and experienced regulatory and therapeutic team to capitalize on existing strong relationships and navigate the complexities of conducting research in this market.

More... »

Quintiles receives Technology Security Award from IDG’s CSO Magazine

Wednesday, January 15, 2014 02:57 PM

Quintiles has been named to the 2014 CSO40 by IDG's CSO magazine for the second year in a row, recognizing its “Trusted Cloud Services Model” which extends internal security controls to cloud service providers. 

More... »

Icon appoints Steve Cutler chief operating officer

Wednesday, January 15, 2014 01:56 PM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced that Dr. Steve Cutler has been appointed to the newly created position of chief operating officer, Icon.

More... »

AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India

Wednesday, January 15, 2014 07:52 AM

Albany Molecular Research, a global contract research and manufacturing organization, has appointed Vijay Kumar Batra to managing director, AMRI India, effective Jan. 2. Batra will report to Steve Hagen, Ph.D., senior vice president of manufacturing and pharmaceuticals.

More... »

MIMETAS appoints Todd Chappell general manager, U.S. Affairs

Tuesday, January 7, 2014 09:00 AM

BioHealth Innovation (BHI) and MIMETAS, a developer of organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models, have announced Todd Chappell, MBA, an entrepreneur-in-residence for BHI, has been named general manager, U.S. Affairs for MIMETAS. A Netherlands-based company, MIMETAS is establishing its offices within BHI's headquarters in Rockville, Md. MIMETAS and BHI created a U.S. subsidiary of MIMETAS to access the clinical, regulatory and scientific resources available in Central Maryland and to access the U.S. marketplace, the largest life sciences market in the world.

More... »

Soligenix appoints Richard Straube chief medical officer

Tuesday, January 7, 2014 08:00 AM

Soligenix, a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, has appointed Richard Straube, M.D., as its senior vice president and chief medical officer.

More... »

Ajinomoto Althea appoints J. David Enloe Jr. president and CEO

Tuesday, January 7, 2014 07:00 AM

Ajinomoto Althea, a contract manufacturing organization providing development and manufacturing services for biotechnology and pharmaceutical companies, has appointed J. David Enloe Jr. president and CEO. Enloe will be responsible for developing strategies to support the company's continued growth.

More... »

Aeterna Zentaris appoints Richard Sachse chief scientific officer

Friday, January 3, 2014 09:51 AM

Aeterna Zentaris, a specialty biopharmaceutical company, has appointed Richard Sachse, M.D., Ph.D., senior vice president, chief scientific officer. Before joining Aeterna Zentaris, Sachse was vice president, head of Global Translational Medicine at Boehringer Ingelheim.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs